Common use of Laboratory Procedures Clause in Contracts

Laboratory Procedures. i. The laboratory utilized for blood and urine testing shall be designated by the County. ii. Strict chain of custody procedures must be followed for all samples as set by NIDA. A split sample shall be reserved in all cases for an independent analysis in the event of a positive test result. All samples must be stored in a scientifically acceptable preservation manner as established by NIDA. iii. All positive confirmed samples and related paperwork must be retained by the laboratory for at least one year or for the duration of any grievance, disciplinary action or legal proceedings regarding the sample, whichever is longer. At the conclusion of said period, the sample is to be destroyed along with laboratory maintained paperwork. iv. The laboratory is authorized to test only for the following drugs or classes of drugs: marijuana metabolites, cocaine metabolites, opiate metabolites, Phencyclidine and amphetamines. The laboratory shall test only for these substances within the limits of initial and confirmation tests as currently defined by DHHS/SAMHSA. Initial testing will consist of a preliminary immunoassay (EMIT Screen). If initial testing results are negative, testing shall be discontinued. v. Under this Agreement, the following cutoff levels shall be used in determining test results as positive or negative: Drug Class. Prelim. Cutoff Confirm. Cutoff Marijuana metabolites 100 ng/ml 15 ng/ml Cocaine metabolites 300 ng/ml 150 ng/ml Opiate metabolites Phencyclidine 2,000 ng/ml 25 ng/ml 2,000 ng/ml 25 ng/ml Amphetamines 1,000 ng/ml 500 /ml vi. All initial and confirmatory testing shall be performed at a certified laboratory and not at any individual collection site. vii. The laboratory will report to the MRO. Upon receipt of an initial positive test, the MRO shall investigate whether there are other alternative medical explanations. The MRO shall contact the Employee to request a valid prescription or other lawful authorization to use such substance, or to determine whether some other reasonable alternative medical explanation exists. Employees shall have 10 business days to submit such information to the MRO after being contacted. The MRO shall only report a positive result to the County in the case where both the preliminary and confirmatory test results are positive as to the same sample and the MRO's independent investigation provides no reasonable alternative medical explanation. viii. In the event that tests are altered, invalid, diluted positive or positive test results, upon request to the MRO, each covered Employee will be provided with a report of the confirmed positive results of each test that includes the types of tests conducted, the results of each test, the detection level used by the laboratory and any other information provided to the County by the laboratory.

Laboratory Procedures. i. The laboratory utilized for blood and urine testing shall will be designated by the County. iiEmployer after a recommendation of the Teamster Local 436 prior to March 1, of each calendar year in which testing is to take place. The laboratory must have a current certific Testing Accreditation standards as well as proof that it is operating with Department of Health and Human Services/Substance abuse and Mental Health Services Administration (SAMHSA) certification. Strict chain of custody procedures must be followed for all samples as set by NIDA. The Employer and members of Teamsters Local 436 agree that security of submitted biological samples is such a paramount issue that any breach of the chain of custody or apparent tampering with sample integrity results immediately in an invalid sample that may not be used for any purposes. A split sample shall be reserved in all cases for an independent analysis in the event of a positive test result. All samples must be stored in a scientifically acceptable preservation manner as established by NIDA. iii. All positive confirmed samples and related paperwork must be retained by the laboratory for at least one year or for the duration of any grievance, disciplinary action or legal proceedings regarding the sample, whichever is longer. At the conclusion of said period, the sample is to be destroyed along with laboratory maintained paperwork. iv. The laboratory is authorized to test only for the following drugs or classes of drugs: marijuana metabolites, cocaine metabolites, opiate metabolites, Phencyclidine and amphetamines. The laboratory shall test only for these substances within the limits of initial and confirmation tests as currently defined by DHHS/SAMHSA. Initial testing will consist of a preliminary immunoassay (EMIT Screen). If initial testing results are negative, testing shall be discontinued. v. . If initial testing results are positive, the results shall be confirmed using gas chromatography/mass spectrometry (GS/MS) techniques. Under this Agreement, the following cutoff levels shall be used in determining test results as positive or negative: Drug Class. Prelim. Cutoff Confirm. Cutoff Marijuana metabolites 100 ng/ml 15 ng/ml Cocaine metabolites 300 ng/ml 150 ng/ml Opiate metabolites Phencyclidine 2,000 ng/ml 25 2,000 ng/ml 2,000 Phencyclidine 25 ng/ml 25 ng/ml Amphetamines 1,000 ng/ml 500 /ml ving/ml alternative medical explanations, positive results in the case where both the preliminary and confirmatory test results are positive as to the same sample and the explanation. All initial and confirmatory testing shall be performed at a certified laboratory and not at any individual collection site. vii. The laboratory will report to the MRO. Upon receipt of an initial positive test, the MRO shall investigate whether there are other alternative medical explanations. The MRO shall contact the Employee to request a valid prescription or other lawful authorization to use such substance, or to determine whether some other reasonable alternative medical explanation exists. Employees shall have 10 business days to submit such information to the MRO after being contacted. The MRO shall only report a positive result to the County in the case where both the preliminary and confirmatory test results are positive as to the same sample and the MRO's independent investigation provides no reasonable alternative medical explanation. viii. In the event that tests are altered, invalid, diluted positive or positive test results, upon request to the MRO, each covered Employee employee will be provided with a report of the confirmed positive results of each test that includes the types of tests conducted, the results of each test, the detection level used by the laboratory and any other information provided to the County Employer by the laboratory.

Laboratory Procedures. i. The laboratory utilized for blood and urine testing shall be designated by the County. ii. Strict chain of custody procedures must be followed for all samples as set by NIDA. A split sample shall be reserved in all cases for an independent analysis in the event of a positive test result. All samples must be stored in a scientifically acceptable preservation manner as established by NIDA. iii. All positive confirmed samples and related paperwork must be retained by the laboratory for at least one year or for the duration of any grievance, disciplinary action action, or legal proceedings regarding the sample, whichever is longer. At the conclusion of said period, the sample is to be destroyed along with laboratory laboratory- maintained paperwork. iv. The laboratory is authorized to test only for the following drugs or classes of drugs: marijuana metabolites, cocaine metabolites, opiate metabolites, Phencyclidine phencyclidine, and amphetamines. The laboratory shall test only for these substances within the limits of initial and confirmation tests as currently defined by DHHS/SAMHSA. Initial testing will consist of a preliminary immunoassay (EMIT Screen). If initial testing results are negative, testing shall be discontinued. v. Under this Agreement, the following cutoff levels shall be used in determining test results as positive or negative: Drug Class. Class Prelim. Cutoff Confirm. Cutoff Marijuana metabolites 100 ng/ml 15 ng/ml Cocaine metabolites 300 ng/ml 150 ng/ml Opiate metabolites Phencyclidine 2,000 ng/ml 25 2,000 ng/ml 2,000 Phencyclidine 25 ng/ml 25 ng/ml Amphetamines 1,000 ng/ml 500 /ml500/ml vi. All initial and confirmatory testing shall be performed at a certified laboratory and not at any individual collection site. vii. The laboratory will report to the MRO. Upon receipt of an initial positive test, the MRO shall investigate whether there are other alternative medical explanations. The MRO shall contact the Employee to request a valid prescription or other lawful authorization to use such each substance, or to determine whether some other reasonable alternative medical explanation exists. Employees shall have 10 business days to submit such information to the MRO after being contacted. The MRO shall only report a positive result to the County in the case where both the preliminary and confirmatory test results are positive as to the same sample and the MRO's ’s independent investigation provides no reasonable alternative medical explanation. viii. In the event that tests are altered, invalid, diluted positive or positive test results, upon request to the MRO, ; each covered Employee will be provided with a report of the confirmed positive results of each test that includes the types of and tests conducted, the results of each test, the detection level used by the laboratory and any other information provided to the County by the laboratory.

Laboratory Procedures. i. 1. The laboratory utilized for blood and urine testing shall be designated by the County. ii2. Strict chain of custody procedures must be followed for all samples as set by NIDA. A split sample shall be reserved in all cases for an independent analysis in the event of a positive test result. All samples must be stored in a scientifically acceptable preservation manner as established by NIDA. iii3. All positive confirmed samples and related paperwork must be retained by the laboratory for at least one year or for the duration of any grievance, disciplinary action or legal proceedings regarding the sample, whichever is longer. At the conclusion of said period, the sample is to be destroyed along with laboratory maintained paperwork. iv4. The laboratory is authorized to test only for the following drugs or classes of drugs: marijuana metabolites, cocaine metabolites, opiate metabolites, Phencyclidine and amphetamines. The laboratory shall test only for these substances within the limits of initial and confirmation tests as currently defined by DHHS/SAMHSA. Initial testing will consist of a preliminary immunoassay (EMIT Screen). If initial testing results are negative, testing shall be discontinued. v. 5. Under this Agreement, the following cutoff levels shall be used in determining test results as positive or negative: Drug Class. Prelim. Cutoff Confirm. Cutoff Marijuana metabolites 100 ng/ml 15 ng/ml Cocaine metabolites 300 ng/ml 150 ng/ml Opiate metabolites Phencyclidine 2,000 ng/ml 25 ng/ml 2,000 ng/ml 25 ng/ml Amphetamines 1,000 ng/ml 500 /ml vi6. All initial and confirmatory testing shall be performed at a certified laboratory and not at any individual collection site. vii7. The laboratory will report to the MRO. Upon receipt of an initial positive test, the MRO shall investigate whether there are other alternative medical explanations. The MRO shall contact the Employee to request a valid prescription or other lawful authorization to use such substance, or to determine whether some other reasonable alternative medical explanation exists. Employees shall have 10 business days to submit such information to the MRO after being contacted. The MRO shall only report a positive result to the County in the case where both the preliminary and confirmatory test results are positive as to the same sample and the MRO's independent investigation provides no reasonable alternative medical explanation. viii8. In the event that tests are altered, invalid, diluted positive or positive test results, upon request to the MRO, each covered Employee will be provided with a report of the confirmed positive results of each test that includes the types of tests conducted, the results of each test, the detection level used by the laboratory and any other information provided to the County by the laboratory.

Laboratory Procedures. i. The laboratory utilized for blood and urine testing shall will be designated by the County. iiEmployer after a recommendation of the Teamster Local 436 prior to March 1, of each calendar year in which testing is to take place. The laboratory must have a c Drug Testing Accreditation standards as well as proof that it is operating with Department of Health and Human Services/Substance abuse and Mental Health Services Administration (SAMHSA) certification. Strict chain of custody procedures must be followed for all samples as set by NIDA. The Employer and members of Teamsters Local 436 agree that security of submitted biological samples is such a paramount issue that any breach of the chain of custody or apparent tampering with sample integrity results immediately in an invalid sample that may not be used for any purposes. A split sample shall be reserved in all cases for an independent analysis in the event of a positive test result. All samples must be stored in a scientifically acceptable preservation manner as established by NIDA. iii. All positive confirmed samples and related paperwork must be retained by the laboratory for at least one year or for the duration of any grievance, disciplinary action action, or legal proceedings regarding the sample, whichever is longer. At the conclusion of said period, the sample is to be destroyed along with laboratory maintained paperwork. iv. The laboratory is authorized to test only for the following drugs or classes of drugs: marijuana ; Marijuana metabolites, cocaine metabolites, opiate metabolites, Phencyclidine Phencyclidine, and amphetamines. The laboratory shall test only for these substances within the limits of initial and confirmation tests as currently defined by DHHS/SAMHSA. Initial testing will consist of a preliminary immunoassay (EMIT Screen). If initial testing results are negative, testing shall be discontinued. v. . If initial testing results are positive, the results shall be confirmed using gas chromatography/mass spectrometry (GS/MS) techniques. Under this Agreement, the following cutoff levels shall be used in determining test results as positive or negative: Drug Class. Prelim. Cutoff Confirm. Cutoff Marijuana metabolites 100 ng/ml 15 ng/ml Cocaine metabolites 300 ng/ml 150 ng/ml Opiate metabolites Phencyclidine 2,000 ng/ml 25 2,000 ng/ml 2,000 Phencyclidine 25 ng/ml 25 ng/ml Amphetamines 1,000 ng/ml 500 /ml vi. All initial and confirmatory testing shall be performed at a certified ng/ml alternative medical explanations, positive results in the case where both the laboratory and not at any individual collection site. vii. The laboratory will report to the MRO. Upon receipt of an initial positive test, the MRO shall investigate whether there are other alternative medical explanations. The MRO shall contact the Employee to request a valid prescription or other lawful authorization to use such substance, or to determine whether some other reasonable alternative medical explanation exists. Employees shall have 10 business days to submit such information to the MRO after being contacted. The MRO shall only report a positive result to the County in the case where both the preliminary and confirmatory test results are positive as to the same sample and the MRO's independent investigation provides no reasonable alternative medical explanation. viii. In the event that tests are altered, invalid, diluted positive or positive test results, upon request to the MRO, each covered Employee employee will be provided with a report of the confirmed positive results of each test that includes the types of tests conducted, the results of each test, the detection level used by the laboratory and any other information provided to the County Employer by the laboratory.

Laboratory Procedures. i. The laboratory utilized for blood and urine testing shall be designated by the County. ii. Strict chain of custody procedures must be followed for all samples as set by NIDA. A split sample shall be reserved in all cases for an independent analysis in the event of a positive test result. All samples must be stored in a scientifically acceptable preservation manner as established by NIDA. iii. All positive confirmed samples and related paperwork must be retained by the laboratory for at least one year or for the duration of any grievance, disciplinary action or legal proceedings regarding the sample, whichever is longer. At the conclusion of said period, the sample is to be destroyed along with laboratory laboratory-maintained paperwork. iv. The laboratory is authorized to test only for the following drugs drugs. or classes of drugs: marijuana metabolites, cocaine metabolites, opiate metabolites, Phencyclidine and amphetamines. The laboratory shall test only for these substances within the limits of initial and confirmation tests as currently defined by DHHS/SAMHSA. Initial testing will consist of a preliminary immunoassay (EMIT Screen). If initial testing results are negative, testing shall be discontinued. v. Under this Agreement, the following cutoff levels shall be used in determining test results as positive or negative: Drug Class. Prelim. Cutoff Confirm. Cutoff Marijuana metabolites 100 ng/ml 15 ng/ml Cocaine metabolites 300 ng/ml 150 ng/ml Opiate metabolites Phencyclidine 2,000 ng/ml 25 2,000 ng/ml 2,000 Phencyclidine 25 ng/ml 25 ng/ml Amphetamines 1,000 ng/ml 500 /ml /ml vi. All initial and confirmatory testing shall be performed at a certified laboratory and not at any individual collection site. vii. The laboratory will report to the MRO. Upon receipt of an initial positive test, the MRO shall investigate whether there are other alternative medical explanations. The MRO shall contact the Employee to request a valid prescription or other lawful authorization to use such substance, or to determine whether some other reasonable alternative medical explanation exists. Employees shall have 10 business days to submit such information to the MRO after being contacted. The MRO shall only report a positive result to the County in the case where both the preliminary and confirmatory test results are positive as to the same sample and the MRO's independent investigation provides no reasonable alternative medical explanation. viii. In the event that tests are altered, invalid, diluted positive or positive test results, upon request to the MRO, each covered Employee will be provided with a report of the confirmed positive results of each test that includes the types of tests conducted, the results of each test, the detection level used by the laboratory and any other information provided to the County by the laboratory.